| Market Cap | €21.77B | |
| Enterprise Value | €24.38B | |
| Revenue | €12.80B | +20.4% |
| Gross Profit | €4.25B | +62.6% |
| EBITDA | €1.99B | +145.8% |
| Net Income | — | — |
| Diluted EPS | €0.94 | −89.7% |
| Free Cash Flow | €1.13B | +59.6% |
| DPS (FY2024) | — |
| Trailing yield | — |
| Payout ratio | — |
| Growth streak | — |
| 5y DPS growth | — |
| Fiscal year | DPS | YoY | Basis |
|---|---|---|---|
| FY20242024-12-31 | — | — | reported |
| FY20232023-12-31 | — | — | reported |
| FY20222022-12-31 | — | — | reported |
| Ratio | 2022 | 2023 | 2024 | Trend · 3y | vs own |
|---|---|---|---|---|---|
| ▾Margins | |||||
| Gross Margin | 32.06% | 24.57% | 33.17% | 83% | |
| Operating Margin | 8.13% | −4.68% | 4.38% | 50% | |
| EBITDA Margin | — | 7.62% | 15.56% | 75% | |
| NOPAT Margin | 6.43% | −3.69% | 2.87% | 50% | |
| Net Margin | 20.26% | 20.11% | — | — | |
| FCF Margin | — | 6.68% | 8.85% | 75% | |
| FCFF Margin | — | — | 10.01% | — | 50% |
| FCFE Margin | — | 1.59% | 10.79% | 75% | |
| OCF Margin | — | 11.90% | 13.89% | 75% | |
| Gross Profitability | 15.46% | 7.62% | 12.58% | 50% | |
| Capex Intensity | — | 5.22% | 5.04% | 25% | |
| ▸Returns on Capital · 6 ratios | |||||
| ▸DuPont factors (ROE drivers) · 4 ratios | |||||
| ▸Earnings quality · 7 ratios | |||||
| ▸Liquidity & coverage · 9 ratios | |||||
| ▸Leverage · 7 ratios | |||||
| ▸Working capital · 8 ratios | |||||
| ▸Capital allocation · 5 ratios | |||||
| ▸Other · 1 ratios | |||||
| Line | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | €8.39B | €10.63B | €12.80B |
| YoY % | +26.7% | +20.4% | |
| Cost of Revenue | €5.70B | €8.02B | €8.55B |
| YoY % | +40.6% | +6.7% | |
| Gross Profit | €2.69B | €2.61B | €4.25B |
| YoY % | -2.9% | +62.6% | |
| R&D Expense | €295.0M | €652.0M | €888.0M |
| YoY % | +121.0% | +36.2% | |
| Selling & Marketing Expense | €1.24B | €1.51B | €1.80B |
| YoY % | +22.4% | +19.1% | |
| SG&A Expense | €534.0M | €1.01B | €1.04B |
| YoY % | +90.1% | +2.3% | |
| Operating Income | €682.0M | -€497.0M | €561.0M |
| Interest Expense | €159.0M | €283.0M | €225.0M |
| YoY % | +78.0% | -20.5% | |
| Interest & Investment Income | €71.0M | €133.0M | €91.0M |
| YoY % | +87.3% | -31.6% | |
| Equity Method Income | €12.0M | -€6.0M | -€5.0M |
| Pretax Income | €594.0M | -€647.0M | €427.0M |
| Income Tax | €124.0M | -€18.0M | €147.0M |
| Income from Continuing Operations | €475.0M | -€636.0M | €280.0M |
| Income from Discontinued Operations | €1.24B | €2.79B | €0 |
| YoY % | +124.9% | -100.0% | |
| Net Income (incl. NCI) | €1.72B | €2.15B | €280.0M |
| YoY % | +25.5% | -87.0% | |
| Minority Interest (P&L) | €15.0M | €16.0M | €30.0M |
| YoY % | +6.7% | +87.5% | |
| Net Income to Common | €1.69B | €2.13B | €250.0M |
| YoY % | +25.8% | -88.3% | |
| EPS (Basic) | €9.80 | €9.14 | €0.94 |
| YoY % | -6.7% | -89.7% | |
| EPS (Diluted) | €9.77 | €9.13 | €0.94 |
| YoY % | -6.6% | -89.7% |
Statement lines are XBRL facts as filed with the company's home regulator (SEC EDGAR for US filers; ESEF/EDINET and other national regulators for foreign filers); ratios and other derived figures are computed from them. A blank cell means the tag was absent — never imputed.
